172 related articles for article (PubMed ID: 37493020)
1. Comparative Effectiveness of Long-Term Maintenance Beta-Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention.
Lee M; Lee K; Kim DW; Cho JS; Kim TS; Kwon J; Kim CJ; Park CS; Kim HY; Yoo KD; Jeon DS; Chang K; Kim MC; Jeong MH; Ahn Y; Park MW
J Am Heart Assoc; 2023 Aug; 12(15):e028976. PubMed ID: 37493020
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study.
Holt A; Blanche P; Zareini B; Rajan D; El-Sheikh M; Schjerning AM; Schou M; Torp-Pedersen C; McGettigan P; Gislason GH; Lamberts M
Eur Heart J; 2021 Mar; 42(9):907-914. PubMed ID: 33428707
[TBL] [Abstract][Full Text] [Related]
3. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675
[TBL] [Abstract][Full Text] [Related]
5. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
[TBL] [Abstract][Full Text] [Related]
6. Impact of Carvedilol versus β1-selective β blockers (bisoprolol, metoprolol, and nebivolol) in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Seo GW; Kim DK; Kim KH; Seol SH; Jin HY; Yang TH; Ahn Y; Jeong MH; Song PS; Kim DI;
Am J Cardiol; 2015 Nov; 116(10):1502-8. PubMed ID: 26520013
[TBL] [Abstract][Full Text] [Related]
7. Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction.
Choi IJ; Lim S; Choo EH; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Youn HJ; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
JACC Cardiovasc Interv; 2021 Nov; 14(22):2431-2443. PubMed ID: 34756537
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
[TBL] [Abstract][Full Text] [Related]
9. Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.
Kim J; Kang D; Park H; Kang M; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY
Eur Heart J; 2020 Oct; 41(37):3521-3529. PubMed ID: 32542362
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
11. Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Taniguchi T; Shiomi H; Morimoto T; Watanabe H; Ono K; Shizuta S; Kato T; Saito N; Kaji S; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Horie M; Kimura T
Am J Cardiol; 2017 Jun; 119(11):1729-1739. PubMed ID: 28407886
[TBL] [Abstract][Full Text] [Related]
12. Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry.
Bruno F; Marengo G; De Filippo O; Wanha W; Leonardi S; Raposeiras Roubin S; Fabris E; Popovic M; Giannino G; Truffa A; Huczek Z; Gaibazzi N; Ielasi A; Cortese B; Borin A; Núñez-Gil IJ; Melis D; Ugo F; Bianco M; Barbieri L; Marchini F; Desperak P; Montalto C; Melendo-Viu M; Elia E; Mancone M; Buono A; Ferrandez-Escarabajal M; Morici N; Scaglione M; Tuttolomondo D; Sardella G; Gasior M; Mazurek M; Gallone G; Campo G; Wojakowski W; Abu-Assi E; Sinagra G; De Ferrari GM; D'Ascenzo F;
J Am Heart Assoc; 2023 Aug; 12(15):e028475. PubMed ID: 37489724
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry.
Chung J; Han JK; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
Korean J Intern Med; 2021 Mar; 36(Suppl 1):S62-S71. PubMed ID: 32615654
[TBL] [Abstract][Full Text] [Related]
14. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P; Bergamaschi L; Gragnano F; Gallinoro E; Cesaro A; Sardu C; Mileva N; Foà A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Esposito G; Morici N; Andrea OJ; Casella G; Mauro C; Vassilev D; Galie N; Santulli G; Marfella R; Calabrò P; Pizzi C; Barbato E
Pharmacol Res; 2023 Jan; 187():106597. PubMed ID: 36470546
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].
Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):874-881. PubMed ID: 30462976
[No Abstract] [Full Text] [Related]
18. Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.
Lee JM; Rhee TM; Kim HK; Hwang D; Lee SH; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Chae SC; Cho MC; Kim CJ; Kim JH; Kim HS; Gwon HC; Jeong MH; Hahn JY;
J Am Heart Assoc; 2019 Dec; 8(24):e013870. PubMed ID: 31818215
[TBL] [Abstract][Full Text] [Related]
19. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
